GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Gross-Profit-to-Asset %
中文

Icon (ICLR) Gross-Profit-to-Asset % : 14.59% (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Icon Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Icon's annualized Gross Profit for the quarter that ended in Dec. 2023 was $2,482 Mil. Icon's average Total Assets over the quarter that ended in Dec. 2023 was $17,011 Mil. Therefore, Icon's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 14.59%.


Icon Gross-Profit-to-Asset % Historical Data

The historical data trend for Icon's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Gross-Profit-to-Asset % Chart

Icon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.61 25.77 14.49 12.81 14.05

Icon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.55 13.53 13.74 14.20 14.59

Competitive Comparison of Icon's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Icon's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icon's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Icon's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Icon's Gross-Profit-to-Asset % falls into.



Icon Gross-Profit-to-Asset % Calculation

Icon's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=2400.227/( (17185.278+16989.863)/ 2 )
=2400.227/17087.5705
=14.05 %

Icon's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=2482.084/( (17031.497+16989.863)/ 2 )
=2482.084/17010.68
=14.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Icon Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Icon's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Icon (ICLR) Business Description

Traded in Other Exchanges
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.